Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.07.05.547858

Fus3 interacts with Gal83, revealing the MAPK crosstalk to Snf1/AMPK to regulate secondary metabolic substrates in filamentous fungi

Abstract

The pheromone MAPK is essential for the vital activities of fungi and is widely identified in filamentous fungi of agricultural, medical, and industrial relevance. The targets have rarely been reported and it is difficult to understand the mechanism of pheromone MAPK signaling pathway. Aflatoxins (AFs), highly carcinogenic natural products, are produced by the secondary metabolism of fungi, such as Aspergillus flavus. Our previous studies demonstrated that Fus3 regulates AFs by modulating substrate levels in Aspergillus flavus, but no mechanism explain that in fungi. Here we show Gal83, a new target of Fus3, and identified the pheromone Fus3-MAPK signaling pathway regulates the Snf1/AMPK energy-sensing pathway to modulate aflatoxins synthesis substrates. In the screening for target proteins of Fus3, the Snf1/AMPK complexes {beta} subunit was identified by using tandem affinity purification and multi-omics, which physically interacted with Fus3 in vivo and vitro and received phosphorylation from Fus3. While neither aflatoxin transcript levels were down-regulated in gal83-mutant and fus3-mutant strains, significant decreases in aflatoxin B1, aflatoxin synthetic substrates levels and gene expression levels of primary metabolic enzymes were shown that both the Fus3-MAPK and Snf1/AMPK pathways could response energy signal. In conclusion, all the evidence unlocks a novel pathway of Fus3-MAPK to regulate AFs synthesis substrates by cross-talking to the Snf1/AMPK complexes. ImportanceAflatoxin poses a great threat to human and animal health and the economy, thus the mechanisms regulating aflatoxin synthesis have been of great interest. We have previously demonstrated that MAPK regulates aflatoxin biosynthesis significantly, but the regulatory mechanism of Fus3-MAPK is not clear. Here we found that Pheromone Fus3-MAPK responds to energy and transmits to Snf1/AMPK through phosphorylation, which regulates the level of secondary metabolic substrates in Aspergillus flavus, as a novel pathway of Fus3-MAPK. Fus3 interacts stably with Gal83 and colocalizes in the cytoplasm and nucleus, directly regulating the levels of aflatoxin synthetic substrates. These data advance our understanding of the regulation of aflatoxin by pheromone MAPK, and the mechanism of pheromone MAPK and Snf1/AMPK crosstalk regulation is confirmed. Overall, this has a positive effect on both fungal regulatory mechanisms and aflatoxin prevention and control.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ma, L., Xing, F., Li, X., Tai, B., Guo, L.. 2023-07-05. Fus3 interacts with Gal83, revealing the MAPK crosstalk to Snf1/AMPK to regulate secondary metabolic substrates in filamentous fungi. https://doi.org/10.1101/2023.07.05.547858

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗